SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-016392
Filing Date
2019-03-28
Accepted
2019-03-28 06:18:09
Documents
7
Period of Report
2019-03-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv517330_8-k.htm 8-K 27200
2 EXHIBIT 1.1 tv517330_ex1-1.htm EX-1.1 192705
3 EXHIBIT 4.1 tv517330_ex4-1.htm EX-4.1 129905
4 EXHIBIT 4.2 tv517330_ex4-2.htm EX-4.2 118320
5 EXHIBIT 5.1 tv517330_ex5-1.htm EX-5.1 10924
6 EXHIBIT 99.1 tv517330_ex99-1.htm EX-99.1 9412
7 EXHIBIT 99.2 tv517330_ex99-2.htm EX-99.2 10553
  Complete submission text file 0001144204-19-016392.txt   500180
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 19709879
SIC: 2834 Pharmaceutical Preparations